Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17 alpha,21-dipropionate in human liver and lung homogenate
- PMID: 6150981
- DOI: 10.1111/j.2042-7158.1984.tb04868.x
Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17 alpha,21-dipropionate in human liver and lung homogenate
Abstract
Tritiated budesonide and beclomethasone 17 alpha,21-dipropionate (BDP) were incubated with the 9000g supernatant of human liver homogenate. BDP was immediately hydrolysed to beclomethasone 17 alpha-propionate (BMP). BMP was then further biotransformed to polar metabolites. Budesonide was rapidly biotransformed (2-4 times more rapidly than BMP) to metabolites of low glucocorticoid potency. The compounds were also incubated with the 1000g supernatant of human lung homogenate. BDP was rapidly hydrolysed to BMP and then more slowly to beclomethasone. Budesonide was not biotransformed in the lung.
Similar articles
-
Pharmacokinetics of butixocort 21-propionate, budesonide, and beclomethasone dipropionate in the rat after intratracheal, intravenous, and oral treatments.Drug Metab Dispos. 1991 Mar-Apr;19(2):546-53. Drug Metab Dispos. 1991. PMID: 1676668
-
Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man.Eur J Clin Pharmacol. 1982;22(6):523-9. doi: 10.1007/BF00609625. Eur J Clin Pharmacol. 1982. PMID: 7128664
-
In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices.Respir Res. 2007 Sep 20;8(1):65. doi: 10.1186/1465-9921-8-65. Respir Res. 2007. PMID: 17883839 Free PMC article.
-
Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide.Respir Med. 1998 Jul;92 Suppl B:2-6. doi: 10.1016/s0954-6111(98)90434-6. Respir Med. 1998. PMID: 10193529 Review.
-
A comparison of beclomethasone dipropionate and budesonide in the treatment of asthma.Br J Clin Pract. 1993 Mar-Apr;47(2):87-93. Br J Clin Pract. 1993. PMID: 8334070 Review.
Cited by
-
Nasal bioavailability and systemic effects of the glucocorticoid budesonide in man.Eur J Clin Pharmacol. 1985;29(4):477-81. doi: 10.1007/BF00613465. Eur J Clin Pharmacol. 1985. PMID: 3912192 Clinical Trial.
-
Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease.Drugs. 1995 Nov;50(5):854-72. doi: 10.2165/00003495-199550050-00006. Drugs. 1995. PMID: 8586030 Review.
-
Topical glucocorticoids with improved risk-benefit ratio. Rationale of a new concept.Drug Saf. 1996 Jun;14(6):375-85. doi: 10.2165/00002018-199614060-00003. Drug Saf. 1996. PMID: 8828015 Review.
-
Anti-inflammatory effects of budesonide in human lung fibroblast are independent of histone deacetylase 2.J Inflamm Res. 2013 Aug 20;6:109-19. doi: 10.2147/JIR.S43736. eCollection 2013. J Inflamm Res. 2013. PMID: 24062615 Free PMC article.
-
Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease.Clin Pharmacokinet. 2004;43(12):803-21. doi: 10.2165/00003088-200443120-00003. Clin Pharmacokinet. 2004. PMID: 15355126 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources